NCIA’s #IndustryEssentials is the premier digital educational series. It features a variety interactive programs that allow us to provide timely, engaging, and essential education at the time you need it.
This edition of NCIA Committee insights, originally aired June 13, featured members of NCIA’s Cannabis Manufacturing, Scientific Advisory and Hemp Committees. They joined us for a detailed discussion on the current landscape of cannabinoid labeling and testing, as well as complications that compound consumer safety and manufacturing concerns.
Cannabinoids-containing products are becoming a very popular category of consumer goods in the United States. Consumers deserve to know whether these products contain cannabinoids that are derived from hemp or cannabis.
Labeling truth is essential to provide cannabinoid information to consumers so that they can make informed purchases and ensure consumer safety. This lack of consistency in labeling can be dangerous to consumers, as there are so many differences between state-to-state for cannabinoids.
This is particularly true for cannabinoid products, which rely on third-party information during the manufacturing process and compliance testing. The interdependence of testing laboratories and manufacturers is a major factor in the label requirements. They must be attainable from a manufacturing perspective without causing undue burden to regulators and should not put public safety and health at risk.
Our panelists examined the state of America’s relatively-monitored market for cannabinoid products, including cannabinoid quantity, cannabinoid contents declarations, label claim verification, and their relationship to consumer safety.
Learning Objectives:
Learn the risks of untested and unlabeled goods, both as a business owner or consumer.
* Examine the current landscape for cannabinoid tests, including how they differ from state to state. Also, learn about the role of third-party labs.
Understand the implications of label claims and label content.
Investigate data integrity issues that prevent consumers from making informed choices
Share the best practices of what the industry can do, what consumers should do, and what regulators must do.
Panelists:
Paul Coble Technology Attorney
Harris Bricken Sliwoski LLP
Matthew Johnson
Vice President, Risk Services
QuadScore Insurance Services
Rhiannon Woo
Co-Founder and CSO
TraceTrust
Keith Butler
The following are some of the most effective ways to increase your ROI:
OP Innovates / Naturia+
Darwin Millard
Owner/Founder /// Vice-chair of the Subcommittee
TSOC LLC /// ASTM International, D37.04, on Cannabis Processing and Handling
This is the third of a series of multi-part #IndustryEssentials webcasts, produced in collaboration with NCIA’s Cannabis Manufacturing Committee. Scientific Advisory Committee. and Hemp Committee. Parts I & II can be viewed by clicking the links below.
Define the Conversation: Minor Novel & Synthetic Cannabinoids:
Meet Minors (Novel Minor Synthetic Cannabinoids, Part II):[View here]
From Lab to Label: Safeguarding Consumers in the Cannabinoid Product Landscape appeared first on The National Cannabis Industry Association.
